AKT1 and cancer: Using whole exome sequencing, targeted sequencing, and transcriptome sequencing, we can analyze the tumor-specific cancer driver genes and the abnormal signaling pathways involved in each patient’s tumor, such as PI3K/AKT, RAS/MAPK, DNA damage repair, cell cycle regulation, and transcriptional regulation (127).